biology of the sarcomere
The sarcomere is a molecular structure that allows skeletal and cardiac muscle cells to contract and generate force.
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.
The sarcomere is a molecular structure that allows skeletal and cardiac muscle cells to contract and generate force.
Heart failure (HF) is a chronic, progressive condition in which the myocardium is unable to pump enough oxygen-rich blood to meet the body’s needs.
In Hypertrophic Cardiomyopathy (HCM), the ventricular myocardium thickens abnormally and has increased contractility.
Understand the challenges of treating advanced heart failure and the burden of disease.
Despite available treatments, many heart failure patients have difficulty managing their disease. Watch this video to hear about John’s journey with his disease.
Cytokinetics is dedicated to helping patient populations which lack effective therapies.
This information is intended for healthcare providers only. Compounds are investigational.
Inclusion in this display does not imply regulatory approval for these compounds in any indication.
Information about all Cytokinetics-sponsored trials can be found at cytokinetics.com/clinical-trials/
You are now exiting the Cytokinetics exhibit for the AHA Scientific Sessions 2020 Virtual Meeting. The link you’ve selected will take you to an external website.